Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 3, p. 234, doi. 10.1038/sj.cgt.7700891
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2006 AND VI 13 AND IP 3
Results: 12
1
2
Growth inhibition efficacy of an adenovirus expressing dual therapeutic genes, wild-type p53, and anti-erbB2 ribozyme, against human bladder cancer cells.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 3, p. 298, doi. 10.1038/sj.cgt.7700892
- By:
- Publication type:
- Article
3
Comparison of recombinant adenovirus and synthetic peptide for DC-based melanoma vaccination.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 3, p. 318, doi. 10.1038/sj.cgt.7700894
- By:
- Publication type:
- Article
4
Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 3, p. 326, doi. 10.1038/sj.cgt.7700890
- By:
- Publication type:
- Article
5
Retrovirus-mediated tk gene therapy of implanted human breast cancer in nude mice under the regulation of Tet-On.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 3, p. 290, doi. 10.1038/sj.cgt.7700889
- By:
- Publication type:
- Article
6
Genetic strategies for brain tumor therapy.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 3, p. 225, doi. 10.1038/sj.cgt.7700886
- By:
- Publication type:
- Article
7
Liposome–DNA complexes infused intravenously inhibit tumor angiogenesis and elicit antitumor activity in dogs with soft tissue sarcoma.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 3, p. 306, doi. 10.1038/sj.cgt.7700895
- By:
- Publication type:
- Article
8
Inhibition of ovarian cancer metastasis by adeno-associated virus-mediated gene transfer of nm23H1 in an orthotopic implantation model.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 3, p. 266, doi. 10.1038/sj.cgt.7700899
- By:
- Publication type:
- Article
9
Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 3, p. 253, doi. 10.1038/sj.cgt.7700900
- By:
- Publication type:
- Article
10
Oncolytic replication-competent adenovirus suppresses tumor angiogenesis through preserved E1A region.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 3, p. 242, doi. 10.1038/sj.cgt.7700902
- By:
- Publication type:
- Article
11
Targeting of autonomous parvoviruses to colon cancer by insertion of Tcf sites in the P4 promoter.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 3, p. 273, doi. 10.1038/sj.cgt.7700904
- By:
- Publication type:
- Article
12
In vitro efficacy of AdTRAIL gene therapy of bladder cancer is enhanced by trichostatin A-mediated restoration of CAR expression and downregulation of cFLIP and Bcl-X<sub>L</sub>.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 3, p. 281, doi. 10.1038/sj.cgt.7700905
- By:
- Publication type:
- Article